These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 35937250

  • 1. Cost-utility analysis of centrally inserted totally implanted access port (PORT) vs. peripherally inserted central catheter (PICC) in the oncology chemotherapy.
    Shao G, Zhou X, Zhang S, Wu S, Dong Y, Dong Z.
    Front Public Health; 2022; 10():942175. PubMed ID: 35937250
    [Abstract] [Full Text] [Related]

  • 2. Peripherally inserted central catheter versus totally implanted venous port for delivering medium- to long-term chemotherapy: A cost-effectiveness analysis based on propensity score matching.
    Wang K, Zhou Y, Huang N, Lu Z, Zhang X.
    J Vasc Access; 2022 May; 23(3):365-374. PubMed ID: 33579176
    [Abstract] [Full Text] [Related]

  • 3. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
    Wu O, McCartney E, Heggie R, Germeni E, Paul J, Soulis E, Dillon S, Ryan C, Sim M, Dixon-Hughes J, Agarwal R, Bodenham A, Menne T, Jones B, Moss J.
    Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
    [Abstract] [Full Text] [Related]

  • 4. Cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer-A health economic evaluation of the PICCPORT trial.
    Taxbro K, Hammarskjöld F, Juhlin D, Hagman H, Bernfort L, Berg S.
    Acta Anaesthesiol Scand; 2020 Mar; 64(3):385-393. PubMed ID: 31721153
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-utility analysis of different venous access devices in breast cancer patients: a decision-based analysis model.
    Chen N, Yang Q, Li YF, Guo Q, Huang Y, Peng JL.
    BMC Health Serv Res; 2023 May 16; 23(1):497. PubMed ID: 37194042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
    Patel GS, Jain K, Kumar R, Strickland AH, Pellegrini L, Slavotinek J, Eaton M, McLeay W, Price T, Ly M, Ullah S, Koczwara B, Kichenadasse G, Karapetis CS.
    Support Care Cancer; 2014 Jan 16; 22(1):121-8. PubMed ID: 24005884
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Economic evaluation of peripherally inserted central catheter and other venous access devices: A scoping review.
    Wang K, Zhong J, Huang N, Zhou Y.
    J Vasc Access; 2020 Nov 16; 21(6):826-837. PubMed ID: 31894710
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port.
    Pinelli F, Barbani F, Defilippo B, Fundarò A, Nella A, Selmi V, Romagnoli S, Villa G.
    Breast Cancer; 2024 Sep 16; 31(5):945-954. PubMed ID: 38980572
    [Abstract] [Full Text] [Related]

  • 15. Clinical effect and safety of venous access ports and peripherally inserted central catheters in patients receiving tumor chemotherapy: a systematic review and meta-analysis.
    He E, Ye K, Zheng H.
    Ann Palliat Med; 2021 Aug 16; 10(8):9105-9113. PubMed ID: 34488396
    [Abstract] [Full Text] [Related]

  • 16. A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: a multicentric Italian experience.
    Martella F, Salutari V, Marchetti C, Pisano C, Di Napoli M, Pietta F, Centineo D, Caringella AM, Musella A, Fioretto L.
    Anticancer Drugs; 2015 Oct 16; 26(9):990-4. PubMed ID: 26241804
    [Abstract] [Full Text] [Related]

  • 17. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.
    Bertoglio S, Cafiero F, Meszaros P, Varaldo E, Blondeaux E, Molinelli C, Minuto M.
    J Vasc Access; 2020 Jul 16; 21(4):460-466. PubMed ID: 31674857
    [Abstract] [Full Text] [Related]

  • 18. Comparison of peripherally inserted central catheters and totally implanted venous access devices as chemotherapy delivery routes in oncology patients: A retrospective cohort study.
    Yun WS, Yang SS.
    Sci Prog; 2021 Jul 16; 104(2):368504211011871. PubMed ID: 33950754
    [Abstract] [Full Text] [Related]

  • 19. Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study.
    Rieger MJ, Schenkel X, Dedic I, Brunn T, Gnannt R, Hofmann M, de Rougemont O, Stolz SM, Rösler W, Studt JD, Balabanov S, Wicki A, Lorch A, Manz MG, Schwotzer R.
    Int J Cancer; 2023 Oct 01; 153(7):1397-1405. PubMed ID: 37254629
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.